10th Annual Hematology and Medical Oncology Board Review: Contemporary Practice 2022

Regular price
$80.00
Sale price
$80.00
Regular price
$0
Sold out
Unit price
Quantity must be 1 or more

Format : 41 Videos + 41 PDFs




File Size : 6.34 GB





Date & Location

Friday, March 11, 2022, 9:00 AM – Monday, March 14, 2022, 1:00 PM EST


Specialties
Specialties – Hematology, Infectious Diseases, Medical Oncology, Oncology and Hematology, Radiation Oncology, Surgical Oncology
Overview

This four-day live course will provide an up-to-date and comprehensive review of the diagnosis, staging, and management of neoplastic disease, including solid tumor and hematologic oncology. Lectures will focus on disease specific topics in gastrointestinal, gynecologic, thoracic, head and neck, genitourinary, soft tissue and skin, and central nervous system oncology, as well as hematologic oncology. Each lecture will conclude with a live Q&A with esteemed MSK course faculty.


Additionally, registered attendees will receive access to an online course syllabus, which includes select PDFs of the faculty presentations (slides) and recorded videos from the course.


Who Should Attend


The target audience for this well-received annual program includes medical oncology professionals – physicians, nurses, pharmacists, fellows and residents.


Objectives

  1. Define state-of-the-science in diagnosis, staging, and therapeutic management of solid tumor cancers and hematologic cancers

  2. Discuss recent treatment advances in solid tumor and hematologic oncology and apply knowledge gained in modern clinical practice

  3. Prepare for ABIM examinations in medical oncology and hematology


Objectives


– Define state-of-the-science in diagnosis, staging, and therapeutic management of solid tumor cancers and hematologic cancers


– Discuss recent treatment advances in solid tumor and hematologic oncology and apply knowledge gained in modern clinical practice


– Prepare for ABIM examinations in medical oncology and hematology


Program :


SOLID TUMOR SESSION

Colon Cancer Leonard B. Saltz, MD


Melanoma Paul B. Chapman, MD


Prostate Cancer Susan F. Slovin, MD, PhD


Kidney Cancer Robert J. Motzer, MD


Urothelial Cancer Gopa Iyer, MD


Testis Cancer Darren R. Feldman, MD


Uterine/Cervix/Other GYN Cancers Carol Aghajanian, MD


Ovarian Cancer Rachel N. Grisham, MD


Breast Cancer: Surgery Hiram S. Cody III, MD, FACS


Breast Cancer: Radiation Therapy Beryl McCormick, MD, FACR


Genetics Zsofia K. Stadler, MD


Small Cell Lung Cancer W. Victoria Lai, MD


Breast Cancer: Adjuvant Therapy Chau T. Dang, MD


Breast Cancer: Advanced Disease Rachel Sanford, MD


Breast Cancer: Hormonal Therapy Julia Brockway-Marchello, MD


Carcinoma of Unknown Primary Anna M. Varghese, MD


Hepatocellular Cancer and Cholangiocarcinoma Ghassan K. Abou-Alfa, MD, MBA


Pancreatic and Neuroendocrine Cancer Eileen M. O’Reilly, MD


Non Small Cell Lung Cancer Gregory J. Riely, MD, PhD


Head and Neck, Thyroid,


Non-melanoma Skin Cancer


Lara A. Dunn, MD


Anal/Rectal Cancer Andrea Cercek, MD


Esophageal/Gastric Cancer David H. Ilson, MD, PhD, FACP, FASCO


CNS Tumors Christian Grommes, MD


Sarcoma Mark A. Dickson, MD


Infectious Disease Susan K. Seo, MD


Mesothelioma Marjorie G. Zauderer, MD


Pharmacology Mrinal M. Gounder, MD


MALIGNANT HEMATOLOGY SESSION


CAR T cells Michael Scordo, MD


Low Grade NHL Andrew D. Zelenetz, MD, PhD


CLL/SLL Lindsey Roeker, MD


DLBCL/MCL/BL Paul Hamlin, MD


HL/T Cell Alison J. Moskowitz, MD


Auto/Allo Gunjan Shah, MD


ALL Mark Blaine Geyer, MD


AML Eytan Stein, MD


MDS/MPN Michael J. Mauro, MD


Myeloma/Amyloid Malin Hultcrantz


BENIGN HEMATOLOGY SESSION


Approach to The Bleeding Patient Rekha Paramewaran, MD


The Role of the New Direct Oral Anticoagulants in Practice


Simon Mantha, MD, MPH


Thrombocytopenia, ITP and Beyond Cy Wilkins, MD


Sickle Cell Disease, Thalassemia Jodi Mones, MD


Recorded/Review Date: March 11-14, 2022;


Original Release Date: April 4, 2022;


Go to full site